PBYI FY 2012 Earnings — Puma Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

PBYIPuma Biotechnology, Inc.

$300M

FY 2012 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0+100.0% YoY

Gross Profit

$0

Operating Income

-$74M

Net Income

-$74M

EPS (Diluted)

$-3.42

Cash Flow

Operating Cash Flow

-$44M

Free Cash Flow

-$45M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$152M

Total Liabilities

$23M

Stockholders' Equity

$129M

Cash & Equivalents

$137M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	-$281,096	+100.0%
Gross Profit	$0	-$281,096	+100.0%
Operating Income	-$74M	-$10M	-632.5%
Net Income	-$74M	-$10M	-626.1%